亿胜生物科技：于中国商业化不含防腐剂单剂量玻璃酸钠滴眼液(0.1%)获批准

新浪港股2024-12-26

热点栏目自选股数据中心行情中心资金流向模拟交易客户端　　亿胜生物科技（01061）发布公告，公司的间接附属公司广东汉丰百盛医药有限公司已取得国家药品监督管理局批准于中华人民共和国（中国，就本公布而言，不包括中国香港特别行政区、中国澳门特别行政区及中国台湾）注册及商业化不含防腐剂单剂量玻璃酸钠滴眼液（0.1%）（获批准产品）。　　获批准产品是一种含有0.1%（0.4ml：...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2494007200?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-26 10:03","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2494007200","market":"hk","top_or_hot":-1,"title":"亿胜生物科技：于中国商业化不含防腐剂单剂量玻璃酸钠滴眼液(0.1%)获批准","media":"新浪港股","content":"<div>\n<p>热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　亿胜生物科技（01061）发布公告，公司的间接附属公司广东汉丰百盛医药有限公司已取得国家药品监督管理局批准于中华人民共和国（中国，就本公布而言，不包括中国香港特别行政区、中国澳门特别行政区及中国台湾）注册及商业化不含防腐剂单剂量玻璃酸钠滴眼液（0.1%）（获批准产品）。\n　　获批准产品是一种含有0.1%（0.4ml：...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-12-26/doc-ineatxus9959772.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>亿胜生物科技：于中国商业化不含防腐剂单剂量玻璃酸钠滴眼液(0.1%)获批准</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n亿胜生物科技：于中国商业化不含防腐剂单剂量玻璃酸钠滴眼液(0.1%)获批准\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-26 10:03 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-12-26/doc-ineatxus9959772.shtml><strong>新浪港股</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　亿胜生物科技（01061）发布公告，公司的间接附属公司广东汉丰百盛医药有限公司已取得国家药品监督管理局批准于中华人民共和国（中国，就本公布而言，不包括中国香港特别行政区、中国澳门特别行政区及中国台湾）注册及商业化不含防腐剂单剂量玻璃酸钠滴眼液（0.1%）（获批准产品）。\n　　获批准产品是一种含有0.1%（0.4ml：...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-12-26/doc-ineatxus9959772.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01061","symbol_name":"亿胜生物科技","start_time":0,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-12-26/doc-ineatxus9959772.shtml","article_id":"2494007200","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2494007200","pubTimestamp":1735178580,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"　　亿胜生物科技发布公告，公司的间接附属公司广东汉丰百盛医药有限公司已取得国家药品监督管理局批准于中华人民共和国注册及商业化不含防腐剂单剂量玻璃酸钠滴眼液。集团其他不含防腐剂单剂量滴眼液产品为妥布霉素滴眼液、左氧氟沙星滴眼液、玻璃酸钠滴眼液、贝复舒滴眼液、盐酸莫西沙星滴眼液及地夸磷索钠滴眼液。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"01061":"亿胜生物科技","BK1161":"生物科技"},"translate_title":"Essex Biotechnology: Approved for commercialization of preservative-free single-dose sodium hyaluronate eye drops (0.1%) in China","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01061":1},"content_text":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　亿胜生物科技（01061）发布公告，公司的间接附属公司广东汉丰百盛医药有限公司已取得国家药品监督管理局批准于中华人民共和国（中国，就本公布而言，不包括中国香港特别行政区、中国澳门特别行政区及中国台湾）注册及商业化不含防腐剂单剂量玻璃酸钠滴眼液（0.1%）（获批准产品）。\n　　获批准产品是一种含有0.1%（0.4ml：0.4mg）玻璃酸钠的不含防腐剂单剂量滴眼液，适用于治疗及缓解各种内源性眼部疾病（如干燥症、史蒂芬强森症候群、干眼症）、外源性眼部疾病以及因手术、药物、外伤和/或配戴隐形眼镜所造成的损伤。集团其他不含防腐剂单剂量滴眼液产品为妥布霉素滴眼液、左氧氟沙星滴眼液、玻璃酸钠滴眼液（0.3%）、贝复舒（rb-bFGF）滴眼液、盐酸莫西沙星滴眼液及地夸磷索钠滴眼液。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2494007200","isCrawlerRequest":true}